Xolair (omalizumab) is a prescription biologic that helps calm down allergic inflammation by targeting IgEthe “match” that lights the allergy fire. It’s given as a subcutaneous injection (a shot under the skin) every few weeks, and it’s used for several conditions where allergies (or allergy-like immune signals) drive symptoms.

Translation: if your immune system is acting like a smoke detector that beeps at toast, Xolair is one of the tools doctors can use to turn down the volume. But it’s not an instant fix, it’s not cheap, and it comes with important safety rulesespecially around rare but serious allergic reactions.

Important: This article is for education onlynot medical advice. Always follow your clinician’s instructions for dosing, observation, and emergency plans.

What is Xolair (omalizumab)?

Xolair is a monoclonal antibody (a lab-made protein) that binds to free IgE in your blood. By lowering “available IgE,” it helps reduce the chain reaction that leads to allergy symptomslike airway inflammation in allergic asthma, swelling and congestion in nasal polyps, or persistent hives in chronic spontaneous urticaria (CSU).

What conditions does Xolair treat?

In the U.S., Xolair is approved for specific uses that typically include:

• Moderate to severe persistent allergic asthma (certain patients ages 6+), as an add-on maintenance treatment.
• Chronic spontaneous urticaria (CSU) (chronic hives) in people ages 12+ whose symptoms aren’t controlled by H1 antihistamines.
• Chronic rhinosinusitis with nasal polyps (CRSwNP) in adults, as an add-on maintenance treatment.
• IgE-mediated food allergy (ages 1+), to reduce allergic reactions that may happen after accidental exposurewhile the person still avoids the trigger foods.

What Xolair does NOT do: It’s not for emergency treatment of an asthma attack or a sudden severe allergic reaction. Think “seatbelt,” not “airbag.”

How Xolair works (without the PhD headache)

IgE is the antibody that helps your body react to allergens. In some people, IgE-driven signals cause over-the-top inflammationwheezing, hives, swelling, congestion, and more.

Xolair binds to circulating IgE, which helps:

• lower free IgE levels over time, and
• reduce activation of immune cells that release histamine and other inflammatory chemicals.

That’s why Xolair can be useful across different conditions that share an IgE-inflammation “theme,” even if the symptoms look totally different (lungs vs. skin vs. sinuses vs. food reactions).

How the injection is given

Route and schedule

Xolair is given as a shot under the skin. Many people receive it:

• every 2 weeks or 4 weeks (asthma, nasal polyps, food allergy), or
• every 4 weeks (CSU).

Where the injection happens

Because Xolair carries a boxed warning for anaphylaxis (a severe allergic reaction), treatment is typically started in a healthcare setting where staff can monitor you afterward and handle emergencies.

After Xolair is established, some patients may be selected for at-home administration using certain device options (with proper training and clinician approval). That selection is based on safety factorsyour clinician is balancing convenience with risk management.

What forms does Xolair come in?

Depending on your prescription and what your clinic or specialty pharmacy provides, you may see:

• Prefilled syringe (different strengths are available)
• Autoinjector (a pen-style device in certain strengths)
• Vial that is prepared for injection in a clinical setting (in some situations)

Real-world tip: Your dose may require more than one injection at a visit. This isn’t a “your body is failing” momentit’s just math and device strengths doing what they do.

Xolair dosage: How dosing is decided

Xolair dosing is condition-specific. Some indications use a dosing table that combines body weight and a baseline total IgE blood level measured before starting treatment. Other indications use a fixed dose.

Dosage for allergic asthma

For asthma, the typical recommended dosing range is 75 mg to 375 mg by subcutaneous injection every 2 or 4 weeks. The exact dose and schedule are based on:

• your pretreatment total IgE (IU/mL), and
• your body weight (kg).

Example (conceptual): Two people can both have “asthma,” but if one weighs significantly more or has a higher IgE level, they may need a higher dose or more frequent dosing. Your clinician uses the FDA dosing tablenot guessworkto select the regimen.

Dosage for chronic rhinosinusitis with nasal polyps (CRSwNP)

For nasal polyps, Xolair is typically dosed 75 mg to 600 mg subcutaneously every 2 or 4 weeks, based on pretreatment total IgE and body weight.

Dosage for IgE-mediated food allergy

For food allergy risk reduction, Xolair is also dosed 75 mg to 600 mg subcutaneously every 2 or 4 weeks, based on pretreatment total IgE and body weight.

Key safety note: Xolair for food allergy is a maintenance treatment to reduce reactions from accidental exposurenot permission to “test your limits.” Food avoidance and a clinician-approved emergency plan still matter.

Dosage for chronic spontaneous urticaria (CSU)

For CSU, dosing is much simpler: 150 mg or 300 mg subcutaneously every 4 weeks.

Unlike asthma and nasal polyps, CSU dosing is not based on IgE levels or body weight. (Yes, that’s as refreshing as it sounds.)

How long does Xolair take to work?

Many people start noticing improvement in about 1 to 4 months (roughly 4 to 16 weeks). The timeline can vary based on the condition being treated and how your body responds.

Practical mindset: Xolair is usually judged like a streaming series, not a TikTokgive it a few “episodes” before deciding whether it’s working (unless you have a serious side effect, in which case: call your clinician immediately).

What if you miss a dose?

If you miss a scheduled injection, contact your prescriber or clinic to reschedule. Don’t double-dose on your own to “catch up.” Because dosing is structured and sometimes weight/IgE-based, the safest move is always to get guidance from your care team.

Side effects of Xolair

All medications have side effects; biologics just tend to come with longer name tags. Xolair’s side effects range from common (and usually manageable) to rare-but-serious.

Common side effects

The most common side effects can vary a bit by condition, dose, and age group, but often include:

• Injection site reactions (redness, swelling, itching, pain, bruising)
• Headache
• Upper respiratory symptoms (like a cold, sore throat, sinus symptoms)
• Joint pain (arthralgia)
• Nausea (not everyone, but it shows up in some groups)
• Dizziness (in some patients/indications)
• Fever (reported in certain pediatric groups, including some food allergy studies)

Helpful detail: Injection site reactions are common with many biologics. They’re often mild to moderate and improve with time. Your clinic may recommend strategies like warming the medication to room temperature (if allowed by instructions), rotating injection sites, or using a cool pack afterward.

Serious side effects (when to get urgent help)

1) Anaphylaxis (boxed warning)

Xolair can cause anaphylaxis, a severe allergic reaction that can be life-threatening. It may happen:

• after the first dose or after many doses, and
• soon after an injectionor, in some cases, later.

Seek emergency care immediately if you have symptoms such as trouble breathing, chest tightness, fainting, severe hives, swelling of the tongue/throat, or feeling like your body is “crashing.” Your care team will tell you how long to stay for monitoring after injections, especially early in treatment.

2) Heart and circulation problems (rare, but discussed in safety communications)

Some safety reviews have discussed a possible increase in certain cardiovascular or cerebrovascular events in patients treated with Xolair, though the overall data picture is complex. If you develop new chest pain, sudden shortness of breath, weakness on one side, or symptoms that feel like an emergency, seek urgent evaluation.

3) Cancer risk: uncertain signal

Older safety discussions noted an uncertain finding around malignancy risk. This doesn’t mean Xolair “causes cancer,” but it does mean clinicians weigh benefits and risks carefullyespecially for long-term use and for people with other risk factors.

4) Parasitic (worm) infections

If you’re at high risk for parasitic infections (based on travel, living situation, or exposure), tell your clinician. Xolair may increase risk in some situations, and your care team may monitor or test as needed.

5) Other rare immune effects

Rare events reported with Xolair include certain inflammatory or immune-related problems. These are uncommon, but they’re part of why regular follow-up matters.

Warnings, precautions, and who should be careful

People who may need extra caution

• Anyone with a history of anaphylaxis (to foods, medications, or other causes)
• People with significant cardiovascular risk factors (talk through the risk/benefit)
• Those at increased risk of parasitic infections
• People with a known latex allergy (device components have changed over time; always confirm the specific product you receive)

Pregnancy and breastfeeding

Data in pregnancy are limited, but pregnancy registries and observational research have been used to better understand outcomes. If you are pregnant, planning pregnancy, or breastfeeding, discuss Xolair with your clinician so they can weigh the known risks of uncontrolled disease versus the available safety data for omalizumab exposure.

Xolair cost: What you might pay (and why it varies so much)

Xolair is a specialty biologic, and the price reflects that. The manufacturer’s list price is often described in the ballpark of $30,000 to $60,000 per year, depending on dose and frequency. Most patients do not pay the list price out of pocketbut the number is still useful for understanding why insurance paperwork can get… spirited.

What affects the cost?

• Your dose (higher dose or more frequent injections usually costs more)
• Your condition (coverage rules and prior authorizations may differ)
• Where you get it (hospital outpatient center vs. clinic vs. specialty pharmacy)
• Insurance type (commercial, marketplace, Medicare/Medicaid, etc.)
• Administration fees (you may be billed for the injection visit and observation time)

Ways people lower out-of-pocket costs

• Manufacturer co-pay programs (often for eligible commercially insured patients)
• Patient assistance programs (for eligible patients who are uninsured or meet certain financial criteria)
• Foundation assistance (sometimes available for certain insurance situations)
• Shopping the site of care (your care team may have options that reduce administration costs)

Worth asking your clinic: “Is this billed under my medical benefit or pharmacy benefit?” The answer can change your copay/coinsurance dramatically.

Are there biosimilars?

In recent years, FDA-approved omalizumab biosimilar products have entered the market. Biosimilars may reduce costs over time, but actual savings depend on insurance coverage, contracts, and availability. If cost is a major barrier, ask your prescriber and pharmacist whether a biosimilar is an option for you.

Storage and handling basics (especially for home use)

If you’re prescribed a prefilled syringe or autoinjector for home use, storage matters. In general, Xolair is typically kept refrigerated (commonly around 36°F to 46°F) and protected from light in the original carton. Some instructions limit how long the product can be out of the refrigerator across time (for example, a combined maximum of about 2 days out of the fridge, depending on the specific product instructions).

Bottom line: Always follow the Instructions for Use for the specific device you have. When in doubt, call your pharmacythis is one of those “better safe than sorry” moments.

Frequently asked questions

Is Xolair a steroid?

No. Xolair is a biologic antibody that targets IgE. It doesn’t work like prednisone or inhaled steroidsthough it’s often used with other medications as add-on therapy.

Will I be on Xolair forever?

Not necessarily. Labels and clinical guidance often emphasize periodically reassessing whether continued therapy is needed based on symptom control and disease severity. Some people stay on it long-term; others taper off with clinician guidance if they’ve achieved stable control.

Can I stop suddenly?

Stopping is a decision to make with your clinician. In many cases, symptoms can gradually return when the medication is discontinued. If you’re considering stopping due to side effects, cost, or lack of benefit, your care team can help plan next steps safely.

What should I track to see if it’s working?

Tracking makes your follow-up visits way more useful. Many clinicians recommend noting:

• asthma rescue inhaler use and night symptoms (asthma)
• hive/itch frequency and severity (CSU)
• smell, congestion, steroid use, and sinus symptoms (nasal polyps)
• accidental exposure reactions, symptoms, and emergency medication use (food allergy)

Conclusion

Xolair is a well-established anti-IgE biologic that’s used for allergic asthma, chronic hives, nasal polyps, andmore recentlyfor reducing allergic reactions from accidental exposure in IgE-mediated food allergy. Its dosing ranges from fixed schedules (like CSU) to personalized dosing tables (like asthma, nasal polyps, and food allergy). The most common side effects include injection site reactions and headaches, while the most serious risk is anaphylaxishence the careful monitoring rules and the emphasis on clinician guidance.

Cost can be significant, but insurance coverage, co-pay programs, and patient assistance options often reduce what people actually pay. If Xolair is being considered for you or a family member, the best next step is a detailed conversation with your clinician about dosing, safety monitoring, expected timeline of benefit, and affordability strategies.

Real-world experiences with Xolair (what the journey can feel like)

Note: The experiences below are composite examplescommon patterns people report in clinics and patient education settings. Everyone’s response is different.

Before the first injection: Many people describe the pre-start phase as “the paperwork boss level.” There may be bloodwork (especially for asthma/food allergy/nasal polyps dosing), prior authorization forms, and calls between a prescriber’s office, a specialty pharmacy, and an insurance plan. Emotionally, people often sit in two feelings at once: hope (finally, something new) and anxiety (the boxed warning sounds intense when you read it at 11:47 p.m.).

The first appointment: Early injections are often done in a clinic with observation afterward. People commonly report mild soreness at the injection sitelike a small bruiseor a little redness or itching that fades. Some bring a book, headphones, or a fully charged phone because observation time can feel like waiting for your flight at the gate: not thrilling, but necessary. A lot of patients say the most reassuring part is watching the staff treat the safety process like routinebecause for them, it is routine.

Weeks 2 to 8: This is the “is it doing anything?” chapter. Some people notice improvements earlyfewer hives, less itch, better breathing, improved smell with nasal polyps. Others see slower progress and need patience. A common CSU pattern is “better by the second or third dose,” but not everyone follows the same script. Asthma patients sometimes notice fewer nighttime symptoms and less rescue inhaler use gradually rather than suddenly. People often say tracking symptoms (a quick note in a phone app) helps them see progress that would otherwise be missed.

Months 3 to 4: Many patients and clinicians evaluate benefit in this window. Some describe a “quiet life upgrade” rather than fireworkslike realizing they went a whole week without planning their day around hives, or they walked up stairs without mentally locating the nearest chair. For food allergy patients and families, the benefit is often described as reduced fear of accidental exposure, while still practicing strict avoidance. The emotional experience can be huge: less hypervigilance, fewer “what if” spirals, and a clearer routine around safety planning.

Cost reality check: A surprisingly common experience is that the price is not a single numberit’s a moving target. People may have one copay in January, a different coinsurance after a deductible resets, and separate bills for administration or facility fees. Patients who feel most “in control” often report asking very specific questions: “Is this buy-and-bill?” “Is it pharmacy benefit?” “Is there a copay card or foundation support?” It’s not glamorous, but it can make the difference between staying on therapy and stopping early.

Living with the routine: Over time, many people say Xolair becomes “just another calendar event,” like oil changes but with better health outcomes. They learn their personal best practices: hydrating before appointments, wearing sleeves that roll up easily, scheduling injections on a day with fewer obligations, and planning a low-key evening afterward if they tend to feel tired. And yesmore than a few people proudly name their injection day snack. (If you’re going to be brave, you might as well be fed.)